University of Warwick, Clinical Sciences Buildings, University Hospital Coventry, Coventry CV2 2DX, UK.
BMC Musculoskelet Disord. 2013 Jul 29;14:222. doi: 10.1186/1471-2474-14-222.
Periprosthetic infection about the knee is a devastating complication that may affect between 1% and 5% of knee replacement. With over 79 000 knee replacements being implanted each year in the UK, periprosthetic infection (PJI) is set to become an important burden of disease and cost to the healthcare economy. One of the important controversies in treatment of PJI is whether a single stage revision operation is superior to a two-stage procedure. This study sought to systematically evaluate the published evidence to determine which technique had lowest reinfection rates.
A systematic review of the literature was undertaken using the MEDLINE and EMBASE databases with the aim to identify existing studies that present the outcomes of each surgical technique. Reinfection rate was the primary outcome measure. Studies of specific subsets of patients such as resistant organisms were excluded.
63 studies were identified that met the inclusion criteria. The majority of which (58) were reports of two-stage revision. Reinfection rated varied between 0% and 41% in two-stage studies, and 0% and 11% in single stage studies. No clinical trials were identified and the majority of studies were observational studies.
Evidence for both one-stage and two-stage revision is largely of low quality. The evidence basis for two-stage revision is significantly larger, and further work into direct comparison between the two techniques should be undertaken as a priority.
膝关节假体周围感染是一种破坏性的并发症,可能影响 1%至 5%的膝关节置换患者。在英国,每年有超过 79000 例膝关节置换术,假体周围感染(PJI)将成为医疗保健经济的一个重要疾病负担和成本。治疗 PJI 的一个重要争议是单阶段翻修手术是否优于两阶段手术。本研究旨在系统评估已发表的证据,以确定哪种技术具有最低的再感染率。
使用 MEDLINE 和 EMBASE 数据库进行系统文献回顾,目的是确定现有研究报告每种手术技术的结果。再感染率是主要的观察指标。排除了特定患者亚组(如耐药菌)的研究。
确定了 63 项符合纳入标准的研究。其中大多数(58 项)是两阶段翻修的报告。两阶段研究的再感染率在 0%至 41%之间,单阶段研究的再感染率在 0%至 11%之间。未发现临床试验,大多数研究为观察性研究。
单阶段和两阶段翻修的证据主要质量较低。两阶段翻修的证据基础明显更大,应优先进行这两种技术之间的直接比较。